Privacy of your health information at NSHA

https://libcat.nshealth.ca/en/permalink/chpams35788
Nova Scotia Health Authority. Legal Services. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1741
Available Online
View Pamphlet
This pamphlet explains how NSHA protects your privacy and confidentiality. Information on how NSHA uses your personal health information, what personal health information the Personal Health Information Act does and does not protect, and your rights under the Act is included. The French version of this pamphlet 1758, "La confidentialité de vos renseignements médicaux à la Régie de la santé de la Nouvelle-Écosse", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Legal Services
Alternate Title
Privacy of your health information at Nova Scotia Health Authority
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Privacy
Health information
Subjects (LCSH)
Privacy
Abstract
This pamphlet explains how NSHA protects your privacy and confidentiality. Information on how NSHA uses your personal health information, what personal health information the Personal Health Information Act does and does not protect, and your rights under the Act is included. The French version of this pamphlet 1758, "La confidentialité de vos renseignements médicaux à la Régie de la santé de la Nouvelle-Écosse", is also available.
Responsibility
Prepared by: NSHA Legal Services
Pamphlet Number
1741
Less detail
Nova Scotia Health Authority. Halifax Infirmary. Neurosciences. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0614
Available Online
View Pamphlet
This pamphlet will help you learn about your halo brace. A halo brace is worn so that your neck fracture heals properly. This is similar to how a plaster cast protects a broken arm or leg while it is healing. This pamphlet gives information about balance and movement, hygiene, best options for clothing and shoes, and pin sites care. Information about halo vests, loose nuts and bolts, common concerns, activity while wearing a halo brace, and how long you will need to wear the halo brace is inclu…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Halifax Infirmary. Neurosciences
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (12 p.) : digital, PDF file
Subjects (MeSH)
Braces
Neck Injuries
Subjects (LCSH)
Orthopedic braces
Neck--Wounds and injuries
Specialty
Nervous System
Abstract
This pamphlet will help you learn about your halo brace. A halo brace is worn so that your neck fracture heals properly. This is similar to how a plaster cast protects a broken arm or leg while it is healing. This pamphlet gives information about balance and movement, hygiene, best options for clothing and shoes, and pin sites care. Information about halo vests, loose nuts and bolts, common concerns, activity while wearing a halo brace, and how long you will need to wear the halo brace is included.
Responsibility
Prepared by: Neurosciences, Halifax Infirmary
Pamphlet Number
0614
Less detail

Prevnar 13 (pneumococcal conjugate vaccine) and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36443
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1889
Available Online
View Pamphlet
Prevnar® 13 is a vaccine that protects against infections caused by the 13 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Prevnar® 13 is, what Str…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Heptavalent Pneumococcal Conjugate Vaccine
Streptococcus pneumoniae
Kidney Diseases
Subjects (LCSH)
Streptococcus pneumoniae
Kidneys--Diseases
Specialty
Nephrology
Abstract
Prevnar® 13 is a vaccine that protects against infections caused by the 13 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Prevnar® 13 is, what Streptococcus pneumoniae is, why you need to get vaccinated, the possible side effects of the vaccine, who should not get the vaccine, and when you should get it.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1889
Less detail

Pneumovax 23 (pneumococcal vaccine polyvalent) and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36445
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1890
Available Online
View Pamphlet
Pneumovax® 23 is a vaccine that protects against infections caused by the 23 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Pneumovax® 23 is, what…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Pneumococcal Vaccines
Streptococcus pneumoniae
Kidney Diseases
Subjects (LCSH)
Pneumococcal vaccine
Streptococcus pneumoniae
Kidneys--Diseases
Specialty
Nephrology
Abstract
Pneumovax® 23 is a vaccine that protects against infections caused by the 23 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Pneumovax® 23 is, what Streptococcus pneumoniae is, why you need to get vaccinated, the possible side effects of the vaccine, who should not get the vaccine, and when you should get it.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1890
Less detail

Tetanus, diphtheria, and pertussis : diseases and vaccines

https://libcat.nshealth.ca/en/permalink/chpams36638
Nova Scotia Health Authority. Public Health. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2047
Available Online
View Pamphlet
Tetanus, diphtheria, and pertussis are very serious diseases that can be prevented by a vaccine. When pregnant women receive the Tdap (tetanus, diphtheria, acellular pertussis) vaccine, it protects their babies from pertussis (also called whooping cough). This pamphlet explains what tetanus, diphtheria, and pertussis are, what the Tdap vaccine is, who should get and not get the vaccine, and possible side effects and risks of the vaccine. A list of symptoms requiring medical attention is include…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Public Health
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Tetanus
Diphtheria
Whooping Cough
Diphtheria-Tetanus-acellular Pertussis Vaccines
Subjects (LCSH)
Tetanus
Diphtheria
Whooping cough
DPT vaccine
Specialty
Emergency
Abstract
Tetanus, diphtheria, and pertussis are very serious diseases that can be prevented by a vaccine. When pregnant women receive the Tdap (tetanus, diphtheria, acellular pertussis) vaccine, it protects their babies from pertussis (also called whooping cough). This pamphlet explains what tetanus, diphtheria, and pertussis are, what the Tdap vaccine is, who should get and not get the vaccine, and possible side effects and risks of the vaccine. A list of symptoms requiring medical attention is included. A list of resources for further info is provided. The French version of this pamphlet 2067, "Tétanos, diphtérie et coqueluche : renseignements sur les maladies et les vaccins", is also available.
Responsibility
Prepared by: Public Health
Pamphlet Number
2047
Less detail

The Highly Sensitized Patient Program (HSP) for kidney transplant patients

https://libcat.nshealth.ca/en/permalink/chpams36746
Nova Scotia Health Authority. Central Zone. Multi-Organ Transplant Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2132
Available Online
View Pamphlet
One of the ways that your body protects itself from infection is by destroying cells it does not recognize as its own. When your body does not recognize a cell, it produces an antibody. Antibodies destroy infections and transplanted tissues (like in a kidney transplant). A highly sensitized patient has a high percentage of antibodies. These antibodies make them more likely to reject an organ after transplant. This pamphlet explains how to know if you are sensitized, what the Highly Sensitized P…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Multi-Organ Transplant Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Kidney transplantation
Subjects (LCSH)
Kidneys--Transplantation
Specialty
Nephrology
Abstract
One of the ways that your body protects itself from infection is by destroying cells it does not recognize as its own. When your body does not recognize a cell, it produces an antibody. Antibodies destroy infections and transplanted tissues (like in a kidney transplant). A highly sensitized patient has a high percentage of antibodies. These antibodies make them more likely to reject an organ after transplant. This pamphlet explains how to know if you are sensitized, what the Highly Sensitized Patient Program is, how the program increases your chance of finding a match, what happens if there is a possible match for you, and what you can do to increase your chances of getting a transplant. A list of resources is included.
Responsibility
Prepared by: Multi-Organ Transplant Program
Pamphlet Number
2132
Less detail

La confidentialité de vos renseignements médicaux à la Régie de la santé de la Nouvelle-Écosse

https://libcat.nshealth.ca/en/permalink/chpams35813
Nova Scotia Health Authority. Legal Services. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1758
Available Online
View Pamphlet
La présente publication explique comment la Régie de la santé de la Nouvelle-Écosse (la Régie) protège votre vie privée et la confidentialité de vos renseignements personnels. La publication vous renseigne sur la manière dont la Régie utilise vos renseignements médicaux personnels, sur les renseignements médicaux personnels qui sont protégés ou non par la loi sur les renseignements médicaux personnels (Personal Health Information Act), et sur vos droits en vertu de la Loi. ; This pamphlet is a …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Legal Services
Alternate Title
Privacy of your health information at NSHA
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Privacy
Health information
Subjects (LCSH)
Privacy
Abstract
La présente publication explique comment la Régie de la santé de la Nouvelle-Écosse (la Régie) protège votre vie privée et la confidentialité de vos renseignements personnels. La publication vous renseigne sur la manière dont la Régie utilise vos renseignements médicaux personnels, sur les renseignements médicaux personnels qui sont protégés ou non par la loi sur les renseignements médicaux personnels (Personal Health Information Act), et sur vos droits en vertu de la Loi.
This pamphlet is a French translation of "Privacy of Your Health Information at NSHA" pamphlet 1741. This pamphlet explains how NSHA protects your privacy and confidentiality. Information on how NSHA uses your personal health information, what personal health information the Personal Health Information Act does and does not protect, and your rights under the Act is included.
Responsibility
Prepared by: NSHA Legal Services
Pamphlet Number
1758
Less detail

Tétanos, diphtérie et coqueluche : renseignements sur les maladies et les vaccins

https://libcat.nshealth.ca/en/permalink/chpams36667
Nova Scotia Health Authority. Public Health. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2067
Available Online
View Pamphlet
Le tétanos, la diphtérie et la coqueluche sont des maladies très graves qu’on peut prévenir par la vaccination. Le vaccin dcaT (contre la diphtérie, la coqueluche acellulaire et le tétanos) administré à une femme enceinte protège son bébé contre la coqueluche. Le dépliant explique ce que sont la diphtérie, la coqueluche et le tétanos, en quoi consiste le vaccin, qui devrait recevoir le vaccin et qui ne devrait pas le recevoir, de même que les effets secondaires et les risques possibles liés au …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Public Health
Alternate Title
Tetanus, diphtheria, and pertussis : diseases and vaccines
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Tetanus
Diphtheria
Whooping Cough
Diphtheria-Tetanus-acellular Pertussis Vaccines
Subjects (LCSH)
Tetanus
Diphtheria
Whooping cough
DPT vaccine
Specialty
Emergency
Abstract
Le tétanos, la diphtérie et la coqueluche sont des maladies très graves qu’on peut prévenir par la vaccination. Le vaccin dcaT (contre la diphtérie, la coqueluche acellulaire et le tétanos) administré à une femme enceinte protège son bébé contre la coqueluche. Le dépliant explique ce que sont la diphtérie, la coqueluche et le tétanos, en quoi consiste le vaccin, qui devrait recevoir le vaccin et qui ne devrait pas le recevoir, de même que les effets secondaires et les risques possibles liés au vaccin. Le dépliant liste aussi les symptômes qui requièrent des soins médicaux ainsi que d’autres sources d’informations.
This is a French translation of the English pamphlet 2047, “Tetanus, Diphtheria, and Pertussis: Diseases and Vaccines”. Tetanus, diphtheria, and pertussis are very serious diseases that can be prevented by a vaccine. When pregnant women receive the Tdap (tetanus, diphtheria, acellular pertussis) vaccine, it protects their babies from pertussis (also called whooping cough). This pamphlet explains what tetanus, diphtheria, and pertussis are, what the Tdap vaccine is, who should get and not get the vaccine, and possible side effects and risks of the vaccine. A list of symptoms requiring medical attention is included. A list of resources for further info is provided.
Responsibility
Prepared by: Public Health
Pamphlet Number
2067
Less detail

Management of Periprosthetic Joint Infection : a global perspective on diagnosis, treatment options, prevention strategies and their economic impact

https://libcat.nshealth.ca/en/permalink/provcat43402
Klaus-Dieter Kühn (ed.). --Berlin, Heidelberg: Springer , c2018.
Available Online
View e-Book
Location
Online
Periprosthetic joint infection (PJI) is among the most serious complications in the field of endoprosthetics. The number of PJIs is increasing worldwide and poses a real interdisciplinary challenge for everyone involved. For the patient concerned, it is necessary to promptly work out an adequate therapy solution to fight off the infection. Both the clinical experience of the surgeon and the proper diagnostic processes are prerequisite for the reliable detection and identification of an infectio…
Available Online
View e-Book
Other Authors
Kühn, Klaus-Dieter
Responsibility
Klaus-Dieter Kühn (ed.)
Place of Publication
Berlin, Heidelberg
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (xviii, 366 p.) : 196 illus. in color
ISBN
9783662544693
9783662544686 (print ed.)
9783662544709 (print ed.)
Subjects (MeSH)
Joint Prosthesis - adverse effects
Prosthesis-Related Infections - prevention & control
Prosthesis-Related Infections - therapy
Specialty
Infectious Disease Medicine
Orthopedic Procedures
Abstract
Periprosthetic joint infection (PJI) is among the most serious complications in the field of endoprosthetics. The number of PJIs is increasing worldwide and poses a real interdisciplinary challenge for everyone involved. For the patient concerned, it is necessary to promptly work out an adequate therapy solution to fight off the infection. Both the clinical experience of the surgeon and the proper diagnostic processes are prerequisite for the reliable detection and identification of an infection. The microbiologist is responsible for identifying the causative germs by screening the patient's synovial fluid and tissue samples. Based on the findings and subsequent resistance testing, the infectious disease specialist can recommend the appropriate antibiotic therapy. Furthermore, the clinical pharmacist is consulted regularly throughout the therapy to discuss the risk of potential drug interactions. The surgeon will proceed with the revision surgery, following defined algorithms. Adequate radical debridement of infected and necrotic surrounding tissue is the most important step towards a successful cure of the infection. Accompanying the surgery, anti-infective agents are given systemically and locally. While systemic application of anti-infectives mainly reduces the number of haematogenic-spreading planktonic germs, local application immediately forms a colonization barrier and protects the implant from sessile biofilm formation. Concurrently, antibiotics are actively released from the implant, resulting in local germ reduction. Thus, local agents are embedded in the concept of surgical PJI treatment as a reliable adjuvant measure and they sustainably support the successful outcome. In one-stage procedures, local agents are released from specialized antibiotic-loaded bone cements, while in two- or multi-stage procedures, local agents are released from corresponding temporary spacers (interim prostheses). Even from an economic standpoint, the combination of systemic and local agent application is meaningful. Furthermore, there are some interesting trends towards the coating of metallic implants to protect against biofilm formation on the implant surface. On the basis of their personal experience, specialists from all over the world present, explain and discuss preventive approaches, appropriate diagnostic strategies for detection, reproducible effective surgical treatments as well as the economic impact of PJI. The reader can use this book as a solid platform for comparing their own approach to PJI treatment with the specialists' recommendations.áá.
Contents
1. Introduction -- 2. Economic Aspects -- 3. Clinical Aspects -- 4. Diagnosis -- 5. Prevention -- 6. Treatment -- 7. Antibiotic-Loaded Bone Cement -- 8. Spacers -- 9. Coating.
Format
e-Book
Location
Online
Less detail

Glutamine in clinical nutrition

https://libcat.nshealth.ca/en/permalink/provcat33651
Rajkumar Rajendram, Victor R. Preedy, Vinood B. Patel, editors. --New York: Humana Press , c2015.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Other Authors
Rajendram, Rajkumar
Preedy, Victor R
Patel, Vinood B
Responsibility
Rajkumar Rajendram, Victor R. Preedy, Vinood B. Patel, editors
Place of Publication
New York
Publisher
Humana Press
Date of Publication
c2015
Physical Description
1 online resource (xxxiv, 551 pages)
Series
Nutrition and Health
Series Title
Nutrition and health (Totowa, N.J.)
ISBN
9781493919321 (electronic bk.)
9781493919314
Subjects (MeSH)
Glutamine - therapeutic use
Nutritional Physiological Phenomena
Subjects (LCSH)
Glutamine
Diet therapy
Contents
Part I. Basic Processes at the Cellular Level and in Animal Models -- 1. Glutamine structure and function: a starter pack -- 2. Amino acid transporters and glutamine -- 3. Role of glutamine transaminases in nitrogen, sulfur, selenium and 1-carbon metabolism -- 4. Glutamine uptake and immunomodulation: an overview - Kenneth Frauwirth -- 5. The role of glutamine and glutamic acid in the pituitary gland involvement in thyroid-stimulating hormone release -- 6. Glucose-independent glutamine-driven TCA cycle in cancer cells -- 7. The role of glutamine synthetase in the glutamine independence in mammary tissue -- 8. Glutamine addiction of cancer cells -- 9. L-[5-11C]-glutamine and metabolic imaging in cancer cells -- 10. Endotoxemia and glutamine -- Part II. Glutamine Use in Critically Ill Patients and Their Diagnosis -- 11. Plasma glutamine and its levels in metabolic stress -- 12. Glutamine supplementation in major surgery and intensive care -- 13. Enteral nutrition supplemented with L-glutamine in patients with sepsis -- 14. Glutamine supplementation in multiple trauma patients -- 15. Glutamine dipeptide and insulin sensitivity in critically ill patients -- 16. Potential for glutamine supplementation in critically ill children -- 17. Glutamine and ammonia in hepatic encephalopathy -- 18. The oral glutamine challenge in liver cirrhosis -- Part III. Glutamine in Normal Metabolism and under Surgical Stress -- 19. Insulin secretion and the glutamine-glutamate-alpha-ketoglutarate axis -- 20. Glutamine-cycling pathway in metabolic syndrome: Systems Biology-Based Characterization of the glutamate-related metabotype and advances for Diagnosis and Treatment in Translational Medicine -- 21. Glutamine and glucagon-like peptide-1 response -- 22. Glutamine pretreatment and surgery for cleft lip/cleft palate in children -- 23. Use of perioperative glutamine dipeptide in parenteral nutrition in surgical hospital patients with malnutrition -- 24. Therapeutic use of glutamine for diabetic foot ulcers and related conditions -- Part IV. Clinical Aspects of Glutamine in the Intestine -- 25. Glutamine protects GI epithelial tight junctions -- 26. Glutamine therapy in colitis models -- 27. Glutamine supplementation and Helicobacter pylori infection -- 28. Small intestinal hypoxic injury and use of arginyl-glutamine dipeptide: applications to pediatrics -- 29. Dipeptide-bound glutamine and the intestinal microcirculation in cancer -- Part V. Clinical Aspects of Glutamine in Certain Patient Populations -- 30. Manganese toxicity and the glutamine-glutamate cycle -- 31. Glutamine and epilepsy -- 32. Glutamine supplementation in glutamine synthetase deficiency -- 33. Plasma antioxidants and glutamine supplementation in HIV -- 34. Glutamine, total antioxidant systems and damage in renal ischemia reperfusion injury -- 35. Protection by glutamine after ischemia/reperfusion injury -- 36. Glutamine and cancer immunosuppression -- 37. Combining exercise with glutamine-supplementation in cancer cachexia metabolism -- 38. Glutamine and skeletal muscle -- 39. Glutamine and myostatin expression in muscle wasting -- 40. Web based resources, and suggested readings.
Format
e-Book
Location
Online
Less detail

Preventing Occupational Exposures to Infectious Disease in Health Care : A Practical Guide

https://libcat.nshealth.ca/en/permalink/provcat45648
Amber Hogan Mitchell. --Cham: Springer , c2020.
Available Online
View e-Book
Location
Online
This book is a practical guide for preventing occupational exposures to bloodborne and infectious disease in health care. It is a timely and essential resource given that people working in healthcare settings sustain a higher incidence of occupational illness than any other industry sector, and at the time of publication of this book we are in the midst of a global pandemic of COVID-19. While the guide is focused on health care primarily, it would be useful for preventing exposures to essential…
Available Online
View e-Book
Author
Mitchell, Amber Hogan
Responsibility
Amber Hogan Mitchell
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2020
Physical Description
1 online resource (xvi, 171 p.) : 28 illus., 13 illus. in color
ISBN
9783030560393
9783030560386 (Print ed.)
9783030560409 (Print ed.)
9783030560416 (Print ed.)
Subjects (MeSH)
Communicable Disease Control
Occupational Exposure - prevention & control
Occupational Health
Safety Management - methods
Specialty
Communicable Disease Control
Occupational Health
Abstract
This book is a practical guide for preventing occupational exposures to bloodborne and infectious disease in health care. It is a timely and essential resource given that people working in healthcare settings sustain a higher incidence of occupational illness than any other industry sector, and at the time of publication of this book we are in the midst of a global pandemic of COVID-19. While the guide is focused on health care primarily, it would be useful for preventing exposures to essential workers in many other industries as well. The guide offers easy-to-follow instruction, all in one place, for creating, implementing, and evaluating occupational health and safety programs. Readers have practical information that they can use now to either build a new program or expand an existing one that protects workers from occupationally associated illness and infection. With a focus on the public health significance of building better, safer programs in health care, the book provides not just the evidence-based or data-driven reasoning behind building successful programs, but also includes sample programs, plans, checklists, campaigns, and record-keeping and surveillance tools. Topics explored among the chapters include: Occupational Safety and Health Administration (OSHA) Regulatory Compliance; Other Regulatory Requirements, National Standards, and Accreditation; Performing a Hazard Assessment and Building an Exposure Control Plan; Engineering Controls and Safer Medical Devices; Personal Protective Equipment Placement and Use; Facing a Modern Pandemic. Preventing Occupational Exposures to Infectious Disease in Health Care is a comprehensive resource for both seasoned and novice professionals with primary, secondary, or ancillary responsibility for occupational or employee health and safety, infection prevention, risk management, or environmental health and safety in a variety of healthcare or patient care settings. It also would appeal to those working in public health, nursing, medical, or clinical technical trades with an interest in infection prevention and control and/or occupational health and infectious disease.
Contents
1. Introduction -- 2. Public Health Significance -- 3. Controlling and Preventing Occupational Illness and Infection -- 4. Microbiology Basics -- 5. Occupational Safety and Health Administration (OSHA) Regulatory Compliance -- 6. Other Regulatory Requirements, National Standards, and Accreditation -- 7. Performing a Hazard Assessment and Building an Exposure Control Plan -- 8. Institutional and Administrative Controls -- 9. Engineering Controls and Safer Medical Devices -- 10. Personal Protective Equipment Placement and Use -- 11. Facing a Modern Pandemic -- 12. Making It All Work -- Appendix A: OSHA Forms for Recording Work-Related Injuries and Illnesses -- Appendix B: Model Exposure Control Plan -- Appendix C: Hazard Communication Safety Data Sheet.
Format
e-Book
Location
Online
Less detail

Varicocele and Male Infertility : A Complete Guide

https://libcat.nshealth.ca/en/permalink/provcat44741
Sandro C Esteves, Chak-Lam Cho, Ahmad Majzoub, Ashok Agarwal, editors. --Cham: Springer , c2019.
Available Online
View e-Book
Location
Online
This unique textbook – the first of its kind – presents a thoughtful and comprehensive discussion of the significance of varicocele and its impact on male fertility. This hot topic is covered from a multitude of angles in seven thematic sections: origin and pathophysiology, clinical evaluation, medical and surgical therapy, controversies, pro and con debates, and clinical case scenarios. The scope of varicocele includes basic and transitional research, genetics, diagnostic testing with conventi…
Available Online
View e-Book
Other Authors
Esteves, Sandro C.
Cho, Chak-Lam
Majzoub, Ahmad
Agarwal, Ashok
Responsibility
Sandro C Esteves, Chak-Lam Cho, Ahmad Majzoub, Ashok Agarwal, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2019
Physical Description
1 online resource (xxvii, 638 p.) : 91 illus., 68 illus. in color
ISBN
9783319791029
9783319791012 (Print ed.)
9783319791036 (Print ed.)
Subjects (MeSH)
Infertility, Male - etiology
Infertility, Male - therapy
Varicocele - complications
Varicocele - diagnosis
Varicocele - surgery
Specialty
Men's Health
Reproductive Medicine
Abstract
This unique textbook – the first of its kind – presents a thoughtful and comprehensive discussion of the significance of varicocele and its impact on male fertility. This hot topic is covered from a multitude of angles in seven thematic sections: origin and pathophysiology, clinical evaluation, medical and surgical therapy, controversies, pro and con debates, and clinical case scenarios. The scope of varicocele includes basic and transitional research, genetics, diagnostic testing with conventional and advanced molecular biology approaches, hormonal control, interventional therapy and assisted reproductive technology (ART). Repair of varicocele, which can be carried out by various methods, not only alleviates oxidative stress-associated infertility but also prevents and protects against the progressive character of varicocele and its consequent upregulations of systemic oxidative stress. Even with the advances in the understanding of this intriguing disease and consensus on some areas such as diagnosis and pathophysiology, substantial controversy still exists, in particular concerning the benefits of treatment and to whom treatment should be offered. Additional chapters discuss, in depth, such controversies surrounding the role of varicocele in male infertility and present clinical case scenarios dealing with management of subclinical and clinical varicocele. A series of editorial comments is provided by the editors at the end of selected chapters, containing an objective and concise summary of the information from each chapter. In addition, chapters open up with key points for quick references and conclude with multiple choice questions and answers for immediate review and retention of the rich content. Generously illustrated, Varicocele and Male Infertility: A Complete Guide represents an invaluable tool for medical students in reproductive medicine as well as researchers and clinicians working in the field of infertility (e.g., urologists, gynecologists, reproductive endocrinologists, and embryologists) and is comprised of chapters written by leading and internationally recognized clinicians and scientists with expertise in varicocele, skillfully edited by leaders in the field.
Contents
Part I: Varicocele Origin and Pathology -- Anatomic theories of varicocele origin -- Scrotal hyperthermia, hormonal disturbances, testicular hypoperfusion, and backflow of toxic metabolites in varicocele -- Genetics and epigenetics of varicocele pathophysiology -- Oxidative stress and varicocele pathophysiology -- Proteomic and metabolomic profile of semen and seminal plasma in varicocele -- Experimental varicocele -- Part II: Clinical Evaluation of Varicocele -- Epidemiology of varicocele in pediatric, adolescent and adult populations -- Association between varicocele and infertility -- Varicocele clinical diagnosis and grading -- Imaging and other diagnostic modalities in varicocele diagnosis -- Conventional semen analysis and specialized sperm function tests in patients with varicocele -- Endocrine testing and the association between varicocele and hypogonadism -- Varicocele and orchialgia -- Part III: Therapy of Varicocele -- The evolution and refinement of varicocele treatment: A historical perspective -- Medical therapy in varicocele-related infertility -- Macroscopic surgical techniques for varicocele repair -- Microscopic surgical techniques for varicocele repair -- Laparoscopic techniques for varicocele repair -- Interventional radiology for varicocele treatment -- Robotic assisted microsurgical varicocelectomy -- Effect of varicocele treatment on conventional semen analysis -- Effect of varicocele treatment on oxidative stress markers and sperm DNA fragmentation -- Effect of varicocele treatment on natural pregnancy outcome -- Effect of varicocele treatment on assisted reproductive technology (ART) pregnancy outcome -- Varicocele and azoospermia -- Prognostic factors for a favorable outcome after varicocele repair in adults with infertility -- Management of recurrent varicocele -- Cost-effectiveness analysis of varicocele repair and assisted reproductive technology -- Management of pediatric and adolescent varicocele -- Part IV: Controversies with Varicocele -- Is varicocele a bilateral disease? -- Why is subclinical varicocele considered a different entity? -- Why is it that not all men with varicocele are infertile? -- Is there a role for testicular biopsy in men with varicocele? -- Should bilateral varicocele repair be recommended in cases of a clinical varicocele and contralateral subclinical varicocele? -- Is there any role for intraoperative ultrasound during varicocele repair? -- Is there any role for indocyanine green angiography in testicular artery preservation during microsurgical subinguinal varicocelectomy? -- Should a varicocele be repaired before assisted reproductive technology treatment? -- Should a varicocele be repaired in non-infertile patients with hypogonadism? -- What should be the ideal control group in clinical trials investigating the role of varicocele and its treatment on fertility outcomes? -- Part V: Debate (Pro and Con) over Varicocele -- Should SDF testing be used in men with varicocele? -- Should varicocele be repaired before ART? -- Should varicocele be repaired in azoospermic infertile men? -- Should varicocele be managed surgically or radiographically? -- Part VI: Clinical Case Scenarios Involving Varicocele -- Grade 1 varicocele and borderline/normal conventional semen analysis -- Grades 2/3 varicocele and normal conventional semen analysis -- Clinical varicocele and severely abnormal semen analysis in a couple considering ART whose female partner is over 36 years old -- Asymptomatic male with left grade 3 varicocele and 2 children desiring vasectomy with low testosterone -- Symptomatic male with subclinical varicocele found on ultrasound evaluation -- Recurrent grade 2/3 varicocele after microsurgical varicocelectomy and abnormal semen parameters in a couple attempting conception for >3 years -- Grade 2/3 varicocele in a 15-year-old healthy boy with normal testis volume (and normal semen analysis) with a history of varicocele and infertility in his father -- Part VII: Clinical Practice Guidelines for Varicocele -- Adult varicocele diagnosis and treatment -- Pediatric and adolescent varicocele diagnosis and treatment -- Sperm DNA fragmentation testing and varicocele -- Grade of evidence on varicocele treatment -- A ‘Strengths-Weakness-Opportunities-Threats’ (SWOT) analysis of varicocele-related infertility and its diagnosis and management.
Format
e-Book
Location
Online
Less detail